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Background: There is ample experimental evidence supporting the hypothesis that the brain 
serotonergic system is involved in the control of chronic social defeat stress (CSDS), 
depression and anxiety. The study aimed to analyze mRNA levels of the serotonergic genes 
in the raphe nuclei of the midbrain that may be associated with chronic social defeats 
consistently shown by male mice in special experimental settings.  
Methodology/Principal Findings: The serotonergic genes were the Tph2, Sert, Maoa and 
Htr1a. The Bdnf, Creb, Cphn, Gapdh, Hprt, B2M, 18S and Actb genes were also studied. 
The experimental groups were composed of male mice with experience of defeats in 21 
daily encounters and male mice with the same track record of defeats followed by a no-
defeat period without agonistic interactions (relative rest for 14 days). It has been shown that 
mRNA levels of the Tph2, Maoa, Sert, Htr1a, Bdnf and Creb genes in the raphe nuclei of 
defeated mice are decreased as compared with the controls. Under CSDS the Cphn, Gapdh, 
Hprt, B2M, 18S, Actb genes are also down-regulated. The expression of the serotonergic 
genes as well as the Cphn and Creb genes is not restored to the control level after the 2 
weeks of relative rest. mRNA levels of other genes are not recovered to the control levels, 
although some up-regulation was observed in rested losers. Significant positive correlations 
were found between the total time of avoidance behavior demonstrated by the 21-day 
defeaters in agonistic interactions and Sert, Maoa, Bdnf, Gapdh and 18S mRNA levels.  
Conclusions: CSDS experience inducing the development of mixed anxious/depression-like 
state in male mice down-regulates the serotonergic genes expression associated with the 
synthesis, inactivation and reception of serotonin. The Bdnf and Creb genes as wells as the 
cell and metabolic Cphn, Gapdh, Hprt, B2M, Actb and 18S genes in the midbrain raphe 
nuclei are also down-regulated under CSDS. Period of relative rest is not enough for most 
genes to recover expression to the control levels.  
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Introduction 
 
The central role of the brain serotonergic system in the mechanisms of stress, anxiety and depression 
was shown in numerous preclinical and clinical studies [1-5]. It has been shown in the experiments 
that prolonged chronic social defeat stress (CSDS) leads to the development of behavioral 
psychopathology in C57BL/6J male mice, which is similar to mixed anxiety/depression-like state in 
humans as indicated by similarities of symptoms, etiology, sensitivity to antidepressants and 
anxiolytics as well as neurochemical changes in the brain of patients [1,3,6].  
It was suggested and confirmed later that some genes whose proteins are involved in the 
mechanisms of agonistic interactions may change their functional activity in the brain areas [7-10]. In 
particular it has been shown that mRNA levels of the serotonergic Maoa and Sert genes in the raphe 
nuclei of the midbrain increased in CBA/Lac mice after 10 days of CSDS [8]. Levels of Tph1 mRNA 
and TPH protein in the dorsal raphe nuclei of rats were found to be up-regulated by a 5-week stress 
[11]. 
The study aimed to explore possible changes in the functional activity of the serotonergic Tph2, 
Sert, Maoa and Htr1a genes whose proteins are involved in the implications of CSDS: tryptophan 
hydroxylase is the rate limiting enzyme of the serotonin (5-HT) pathway; serotonin transporter 
terminates 5-HT action on the postsynaptic membrane by rapidly removing it from the synaptic cleft 
through reuptake; monoamine oxidase A degrades 5-HT in the synaptic cleft and 5HT1A receptors. 
Expression of the neurotrophin Bdnf (brain derived neutrophic factor) and transcription factor Creb 
(cyclic AMP response element binding protein) genes, which are involved into depression and 
antidepressants treatment [12-16] were also studied.  
In this study the focus was on the area of raphe nuclei of midbrain containing the cell bodies of 
serotonergic neurons. The mRNA levels were analyzed in male mice that had a prolonged negative 
social history (21 defeats in daily agonistic interactions). Since the behavioral data indicate that the 
implications of CSDS persist at least two weeks after the cessation of a pathogenic impact [17], the 
expression of the serotonergic genes was also analyzed in a group of 21-time defeaters who were kept 
away from agonistic interactions for 14 days referred to as "a period of relative rest”. The animals are 
special in that they remain in the anxious state and possess other behavioral changes after the relative 
rest [17]. Comparison of mRNA levels for these genes in the defeaters before and after the no-defeat 
period helps answer the question of whether or not the changed levels of the gene expression in the 
raphe nuclei of the "rested” defeaters recover to the control levels after the period of rest. 
 
 
Methods 
 
Animals 
 
Adult male mice of the C57BL/6J strain from a stock maintained in the Animal Facility of the 
Institute of Cytology and Genetics, SD RAS, (Novosibirsk, Russia) were used. The animals were 
housed under standard conditions (12:12 h light/dark regime, switch-on at 8.00 a.m.; food (pellets) 
and water available ad libitum). Mice were weaned at one month of age and housed in groups of 8-10 
in plastic cages (36 x 23 x 12 cm). Experiments were performed on mice 10-12 weeks of age. All 
procedures were in compliance with the European Communities Council Directive of November 24, 
1986 (86/609/EEC).  
 
 
Chronic social defeats 
 
Prolonged experience of social defeats in male mice was induced using the sensory contact model 
[6,18]. Pairs of weight-matched animals were each placed in a steel cage (14 x 28 x 10 cm) bisected  
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Figure 1.  Protocol of the experiment. Detailed explanations are given in the text. Behavior in the 
groups of ‘‘Losers’’ and ‘‘Rested losers’’ was recorded during their respective last encounter. 
 
 
by a perforated transparent partition allowing the animals to see, hear and smell each other, but 
preventing physical contact. The animals were left undisturbed for two or three days to adapt to new 
housing conditions and sensory contact before they were exposed to encounters. Every afternoon 
(14:00-17:00 p.m. local time), the cage lid was replaced by a transparent one, and 5 min later (the 
period necessary for individuals' activation), the partition was removed for 10 minutes to encourage 
agonistic interactions. The superiority of one of the mice was firmly established within two or three 
encounters with the same opponent. The superior mouse would be attacking, biting and chasing 
another, who would be displaying only defensive behavior (sideways postures, upright postures, 
withdrawal, lying on the back or freezing). As a rule, aggressive confrontations between males are 
discontinued by lowering the partition if the strong aggression has lasted 3 min, in some cases, less. 
Each defeated mouse (defeater, loser) was exposed to the same winner for three days, while 
afterwards each loser was placed, once a day after the fight, in an unfamiliar cage with an unfamiliar 
winner behind the partition. Each victorious mouse (winners, aggressors) remained in its original 
cage. This procedure was performed once a day for 21 days and yielded an equal number of winners 
and losers.  
The design of the current experiment is presented in Figure 1. Three groups of animals were 
used. (1) Losers – a group of chronically defeated mice during 21 days of agonistic interactions; (2) 
Rested losers - a group of chronically defeated 21 times mice who were allowed to live for 14 days 
after the last encounter without agonistic interactions (period of relative rest). During this period, each 
of them shared a cage with a winner; the partition between their compartments being down at all 
times, to prevent physical encounters. (3). Controls: the mice that had been housed individually for 
five days. The rationale for this time interval, based on multiple experiments with this model [6,18], is 
that this time gives the best trade-off between group housing and social isolation: 5 days is sufficient 
for group housing to no longer be a factor, and insufficient for the social isolation to factor in.  
To measure mRNA levels in the raphe nuclei of midbrain, all the mice were decapitated 
simultaneously: 21-time losers, 24 hours after the last agonistic interaction; rested losers, immediately 
after 14-day period of relative rest; and the controls, on day 6 of individual housing. The mouse brains 
were removed and chilled rapidly on ice. The raphe nuclei area of midbrain was dissected according 
to the Mouse Brain Atlas [19]. Obtained tissue was rapidly frozen in liquid nitrogen and stored at -70° 
C until use. 
 
Behavioral study  
 
Behavior of each loser was video recorded for 10 min during its last encounter (Figure 1) and the data 
were documented. Furthermore, we needed to know whether both groups of the losers could be 
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considered identical at the time each mouse was defeated in its last encounter. If they were, all the 
differences in genes expression between chronic defeaters and chronic defeaters after the relative rest, 
or lack thereof, could solely be attributed to resting. To find out, the groups were compared in terms 
of behavior. 
During a 10-minute test the following behavioral domains were analyzed in the losers: 1) active 
defense (sideways and upright postures during the aggressor’s attack and repulsion with one or two 
paws); 2) avoidance behavior – flight, avoidance of attacks and approaching aggressor; 3) passive 
defense during aggressor’s attacks - position "on the back" after persecution by the aggressor, 
"freezing" at the approach of an aggressor or at his sudden movement near the loser. In this case the 
loser can freeze in the upright posture; 4) "freezing" evoked by an aggressor's grooming. Several 
categories and new behavioral elements were recorded in the losers during intervals between the 
aggressor’s attacks (s): 5) a posture of “depression”: the loser is sitting with his nose in the cage corner 
or in the sawdust and does not pay any attention to the aggressor’s movements; 6) sniffing – approach 
to the aggressor and an attempt to sniff him.  
The total time (1-6) and number (1-4) of events as well as % of animals demonstrating freezing under 
aggressor’s grooming were measured. If an animal did not display any behavior, all the counts were 
recorded as zero. 
 
 
 
Total RNA extraction and reverse transcription  
 
 
Total RNA was isolated from the tissues using TRIzol (Invitrogen) according to the manufacturer’s 
instructions. Total RNA was quantified by measuring the absorbance at 260 nm. The integrity of total 
RNA was assessed using agarose gel electrophoresis. cDNAs were synthesized using total RNA (1 
μg), random N9 primer (100 ng) and MoMLV reverse transcriptase (200 U, Biosan). Each RT reaction 
was run in duplicate. RNA aliquots were used to confirm the absence of any genomic DNA in each 
sample. 
 
 
Real-time quantitative PCR 
 
 
Bdnf, Creb, Tph2, Sert, Maoa, Htr1a, Cphn, Gapdh, Hprt, B2M, 18S, Actb cDNA levels were 
quantified by SybrGreen-based real-time PCR in a total volume of 25 μl containing an aliquot of the 
RT mixture, dNTPs (200 nM), F and R primers (300 nM), SybrGreen I (1:20000, Invitrogen), 
standard PCR buffer, and hot-start TaqDNA polymerase (0.5 U, Biosan). Amplification was run for 
3 min at 95°C followed by 40 cycles of 6 s at 96°C, 6 s at 60°C, 12 s at 72°C. Fluorescence was 
monitored for 5 s after each cycle at the appropriate melting temperature. To check for the presence of 
non-specific PCR products or primer dimers, a melting curve analysis was performed after the final 
PCR cycle. 
Amplification efficiencies were calculated using a relative standard curve derived from threefold 
serial dilutions of pooled cDNA. In all cases, the amplification efficiency was higher than 90%. RT-
PCR results were quantified using the relative standard curve method. The Cphn, Gapdh, Hprt, B2M, 
Actb and 18S genes were initially used as reference genes for normalization of PCR data. The PCR 
primer sequences are shown in Table 1. 
 
 
Statistical analysis 
Normal distribution and homogeneity of variances were tested by the Shapiro-Wilk’s and Levene’s 
tests, respectively. Statistical analysis of behavioral data was performed using the Kruskal-Wallis one-
way analysis of variance (ANOVA) with factor “groups”.  
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Table 1. Primer sequences 
  
Genes Primer sequences Functions 
Bdnf F 5’-CAAACAAGACACATTACCTTCCT-3’ Brain derived neurotrophic factor 
 R 5’-ATGGTCATCACTCTTCTCACCT-3’  
Creb F 5’-CAGCCACAGATTGCCACATTAG-3’ Cyclic AMP response element binding protein 
 R 5’-CTTATGGAGACTGGATAACTGATG-3’  
Tph2 F 5’-CACCATTGTGACCCTGAATCC-3’ Tryptophan hydroxylase 2 - rate-limiting enzyme of 5-HT synthesis 
 R 5’-AAGCTCGGTGCCGTACATGAG-3’  
Sert F 5’- GCTGAGATGAGGAACGAAGAC-3’ Serotonin transporter protein  
 R 5’- AGGAAGAAGATGATGGCAAAG-3’  
Maoa F 5’-GAATGTCAATGAGCGTCTAGTTC-3’ Monoamine oxidase A, enzyme of 5-HT catabolism 
 R 5’-ATGGTGCATCAACAGGGATCTC-3’  
5ht1a F 5’-TTGGAACTACTTTGGGTTATGG-3’ Serotonin 5HT1A receptors 
 R 5’-ATTGTCAATTTCTTTGGTGAGTG-3’  
Cphn F 5’-GTTTTTTATCTGCACTGCCAAG-3’ 
PPIA   -  peptidylprolyl isomerase A 
(cyclophilin A); enzyme accelerates 
folding of proteins 
 R 5’-TTCTTGCTGGTCTTGCCATTC-3’  
Gapdh F 5’-TGTTCCAGTATGACTCCACTCA-3’ Glyceraldehyde-3-phosphate dehydro-genase; glycolysis enzyme 
 R 5’-GACACCAGTAGACTCCACGACA-3’  
Hprt F 5’-TGAAAAGGACCTCTCGAAGTGT-3’ 
Hypoxanthine-guanine phosphoribo-
syltransferase; synthesis of purine 
nucleotides through the purine salvage 
pathway 
 R 5’-CACTAATGACACAAACGTGATTC-3’  
B2M F 5’-CCCCACTGAGACTGATACATAC-3’ β2-microglobulin; HLA-class I associated protein 
 R 5’-GTATAGCATATTAGAAACTGGATTTG-3’  
Actb F 5’-AGAGGGAAATCGTGCGTGAC-3’ Cytoskeletal structural protein 
 R 5’-CAATAGTGATGACCTGGCCGT-3’  
18S F 5'-CGGCTACCACATCCAAGGAA-3' 
Component of the small eukaryotic 
ribosomal subunit 
 R 5'-GCTGGAATTACCGCGGCT-3'  
 
 
A post hoc pairwise comparison of the groups was made with the Mann-Whitney U test. If RT PCR 
data satisfied normal distribution criteria (for the Cphn, Actb, Gapdh, 18S, Bdnf, Sert, MaoA genes), 
statistical analysis of mRNA levels was performed using one-way ANOVA of the data with factor 
“groups” under consideration – the controls, losers, rested losers - followed by the post hoc 
comparison of the groups using the Bonferoni test or t- test. In other cases (for the Hprt, B2M, Tph2, 
Htr1a and Creb genes), nonparametric Kruskal-Wallis one-way analysis of variance (ANOVA) was 
used with factor “groups” followed by post hoc pairwise comparison of the groups using the Mann-
Whitney U test. Correlations between behavioral parameters and mRNA levels of genes were assessed 
using Spearman's rank correlation coefficient. The data are reported as mean ± SEM. The statistical 
significance was set at  P ≤ 0.05. Experimental groups contained 6 -17 animals.  
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For each experimental sample, the relative amount of mRNA is determined from the appropriate 
standard curve. Since the all reference genes, Cphn, Gapdh, Hprt, B2M, 18S and Actb, changed their 
expression under CSDS in the raphe nuclei of the losers as compared with the controls, we can’t use 
their to obtain a normalized level of the Bdnf, Creb, Tph2, Sert, Maoa, Htr1a genes. The other 
statistical approach was used to reveal differences in serotonergic and other genes expression between 
the experimental groups: the mean of relative amount of mRNA in the control group for each gene 
was taken as 100%, and changes in the losers, rested losers and controls were calculated as % of the 
mean in the controls.  
 
 
 
Results 
 
 
Behavior of the losers in agonistic interactions 
 
         
No differences were found between the groups of “Losers” and “Rested losers” in any of the 
individual or social behaviors measured after the respective 21-day periods of agonistic interactions 
(P > 0.05, Table 2). Therefore, behaviorally, the two groups of the losers could be considered 
identical at the time each mouse defeated its last encounter. Thus, all the differences in genes 
expression between these groups, or lack thereof, could solely be attributed to the period of rest.  
 
 
Table 2. Behavioral data for "Losers" and “Rested losers” before period of rest during their respective 
last encounter. 
 
 
 
      Note: M-W test – Mann-Whitney test, NS – non significant 
 
 
 
 
Behavioral parameters Losers Rested losers M-W test 
Behavior of the losers during aggressors’ attacks 
Active defense Number 11.8 ± 2.2 15.0 ± 3.8 U=27, NS 
 Total time, s 35.1 ± 7.7 54.7 ± 16.4 U=24, NS 
Avoidance Number 9.5 ± 1.6 11.5 ± 2.8 U=29, NS 
 Total time, s 20.4 ± 3.3 26.7 ± 7.2 U=27, NS 
Passive defense Number 5.5 ± 1.8 3.7 ± 2.3 U=23, NS 
 Total time, s 26.0 ± 9.9 18.0 ± 14.3 U=21, NS 
Freezing   % of mice  27  50  NS 
Behavior of the losers in intervals between aggressor's attacks 
Posture of “depression”  Total time, s 8.0 ± 4.9 5.3 ± 2.9 U=30, NS 
Sniffing Total time, s 15.0 ± 4.4 23.3 ± 11.0 U=31, NS 
Number of mice  12 6  
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Cphn, Gapdh, Hprt, 18S, B2M and Actb genes  
 
 
        All genes used as putative “housekeeping” Cphn, Gapdh, Hprt and 18S genes changed their 
expression under CSDS (Figure 2). One way ANOVA revealed a significant influence of the factor 
groups on mRNA level of the Cphn (F (2, 30) = 15.30; P < 0.001), Gapdh (F (2, 31) = 13.85; P< 
0.001), Hprt, (H (2, N = 35) =11.63, P < 0.003) and 18S  (F (2, 32) = 5.17; P < 0.011) genes. Based on 
the post hoc Bonferoni test and U-test as 
compared to the respective levels in the 
controls, mRNA levels of the Cphn, Gapdh, 
Hprt and 18S genes were decreased in the 
losers under SCDS (P < 0.001 for the Cphn 
and Gapdh; P < 0.001 for the Hprt, P < 0.009 
for 18S genes). Cphn mRNA level in rested 
losers was significantly less in comparison 
with the control (P < 0.039). Expression of the 
Gapdh, Hprt and 18S genes did not differ 
significantly in rested losers in comparison 
with the controls and the losers before period 
of rest (P > 0.05). mRNA levels of the B2M 
and Actb genes, which additionally were 
measured as putative reference genes only in 
the losers and controls, were less significantly 
in 21-time losers in comparison with the 
controls  (P < 0.041 for the B2M, P < 0.001 for 
Actb genes; data not shown in Figure 2). 
Obviously we can not use these genes as 
reference genes for our statistical calculations.  
 
 
 
 
 
Bdnf and Creb genes 
                                                                                   
 
One way ANOVA and Kruskel-Wallis ANOVA 
revealed a significant influence of the factor groups on 
mRNA levels of the Bdnf (F (2, 32) = 5.60; P < 0.008) 
and Creb (H (2, N = 34) = 9.7, P < 0.008) genes. 
Based on the post hoc Bonferoni test and U-test 
(Figure 3) as compared to the respective levels in the 
controls, mRNA levels of Bdnf  (P < 0.006) and Creb 
(P < 0.006) genes were decreased in the losers under 
CSDS. Creb mRNA level in rested losers was less in 
comparison with the controls (P < 0.027). Bdnf mRNA 
levels did not differ significantly in rested losers in 
comparison with the controls and the losers before 
period of rest (P > 0.05). 
 
 
 
 
 
Figure 2. Cphn, Gapdh, Hprt and 18S mRNA levels 
in the raphe nuclei of the midbrain in the controls, 
losers and rested losers. Data are presented as % of 
the mean in the controls. For details, see 
explanations in text. * - P < 0.05;  ** - P < 0.01; and 
*** - P < 0.001 vs the controls. 
Figure 3. Bdnf and Creb mRNA levels in the 
raphe nuclei of the midbrain in the controls, 
losers and rested losers. Data are presented as 
% of the mean in the controls. For details, see 
explanations in text.  
* - P < 0.05;  ** - P < 0.01; vs the controls. 
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Tph2, Sert, MaoA and Htr1a genes                                               
 
One way ANOVA revealed a significant 
influence of the factor groups on mRNA level 
of the Tph2 (H (2, N = 34) = 6.55, P <0.038), 
Sert (F (2,32) = 4.99; P < 0.013), Maoa, (F 
(2,32) = 5.52; P < 0.007) and Htr1a (H (2, N = 
32) = 16.18, P < 0.001) genes. Based on the 
post hoc Bonferoni test and U-test (Figure 4) 
as compared to respective levels in the 
controls, mRNA levels of the Tph2, Sert, 
Maoa and Htr1a genes were decreased in the 
losers under CSDS (P < 0.033; P < 0.027; 
P < 0.016; P < 0.001, respectively). In 
comparison with the controls mRNA levels of 
the Tph2 and Htr1a genes were decreased in 
rested losers (P < 0.039 and P < 0.014, 
respectively). Additionally, T-test has 
demonstrated significant differences between 
the controls and rested losers for Sert 
(P < 0.014) and Maoa (P < 0.007) mRNA 
levels. 
  
 
Correlation analysis  
 
Based on Spearman's rank correlation coefficient, there were found significant positive correlations 
between the total time of avoidance behavior and mRNA level of the Gapdh (R = 0.645, P < 0.032), 
Bdnf (R = 0.663, P < 0.026), Sert (R = 0.764, P < 0.006) and Maoa (R = 0.627, P < 0.039) genes in the 
losers. Other correlations between total time of passive or active defense and mRNA level of genes 
failed to reach significance. 
 
 
 
Discussion  
 
First, we need to discuss the problem of the so-called “housekeeping” genes which are used for 
normalization for the RT PCR data. It is assumed that housekeeping genes are expressed in all tissues 
and at the same level at least within one tissue. Our studies show that the expression of  the Cphn, 
Gapdh, Hprt, 18S, B2M and Actb genes used as putative reference genes varies significantly in the 
raphe nuclei of midbrain between the animals of different experimental groups - the losers (and in the 
winners - male mice with positive fighting experience, unpublished data) – as compared with the 
control mice. It became clear that the use of these genes as reference genes for the analysis of 
expression of other genes is hardly possible. Instead, the method for calculating changes in the 
expression of each gene in the losers relative to its expression in the controls has been used. We 
believe this method is a reliable way of assessing changes in gene expression at least for our purpose. 
At the same time, in the ventral tegmental area no significant differences were found in the expression 
of the Cphn, Gapdh and Hprt genes between experimental groups (unpublished data). These 
observations are in agreement with the data obtained in experiments, which demonstrated that 
reference genes may have different expression in different brain areas, for example, in the 
hippocampus and cerebral cortex [20]. Variability of reference genes expression in different tissues 
and experimental situations was also demonstrated in other studies earlier [21-25].  
Figure 4. Tph2, Sert, Maoa and Htrt1a mRNA levels 
in the raphe nuclei of the midbrain in the controls, 
losers and rested losers. Data are presented as % of the 
mean in the controls. For details, see explanations in 
text.  
* - P < 0.05; ***- P < 0.001 vs the controls 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.6
54
3.
1 
: P
os
te
d 
18
 O
ct
 2
01
1
 9
In the losers, changes in functional activity of the genes involved in the processes of intracellular 
protein transport (Cphn) and glycolysis (Gapdh), presented in all nucleated cells (Hprt, B2M and 18S) 
may indicate a profound influence of negative psychoemotional stress on different metabolic and 
cellular processes under CSDS. It is noteworthy that 2 weeks of relative rest without agonistic 
interactions is not enough for most part of genes to recover expression to the control levels, although 
some increase of their expressions was observed in rested losers.  
BDNF and CREB proteins are the key mediators of therapeutic response to antidepressants 
treatment [12,15,16,26-30]. The expression of these genes was shown to alter in animals under CSDS. 
A reduced Bdnf expression was detected in the hippocampus and amygdala after acute social defeat 
stress [31] and in the hippocampus after a 10-day CSDS [32]. In the nuclei accumbens increased level 
of BDNF protein was found in this period [33,34]. In this experiment we found a decrease in the Bdnf 
gene expression in raphe nuclei of the losers after 21 days of defeat experience. Gómez-Lázaro and the 
co-authors [35] also found lowered level of hippocampal BDNF in defeated mice. However earlier, 
there was no found differences in gene expression in the defeaters in comparison with the 
controls in a similar experimental setting [36]. On the one hand, expression of the Bdnf gene may 
be supposed to vary to a different extent in different brain areas depending on their role in pathological 
processes. On the other hand, expression of the Bdnf gene may depend on the duration of defeat 
experience and the stage of pathological state developing under chronic psychoemotional stress. In our 
experiment [1,3,6] it was shown that 10 days of CSDS are accompanied by a high level of anxiety in 
the losers. After 21 days of social confrontations the losers demonstrate a high level of depressiveness 
and generalized anxiety, that is, mixed anxiety/depression state. Dynamic changes in the activity of the 
neurotransmitter systems from norm to severe psychopathology in male mice [1,3,37] may be reason 
of dynamic changes in the expression of the Bdnf gene. Miczek and the co-workers reported [38] that 
continuous subordination stress leads to significantly decreased levels of BDNF in the VTA as 
compared with control levels, whereas intermittent social defeat stress episodes result in increased 
BDNF levels. Our analysis [39] also indicates that BDNF may be involved not only in depression, but 
in animal and human anxiety too [40,41]. Moreover, inactivation of the Bdnf gene may produce 
antidepressant effects [33], and there are numerous data on the opposite, antidepressant effects of 
BDNF in brain [27,42]. It was suggested also [43] that the role of BDNF may depend on its location in 
the neural circuitry. Critical review of the clinical and preclinical studies outlining pharmacological, 
behavioral and genetic evidence demonstrates the contrasting role of BDNF in mood regulation and 
antidepressant effects throughout the brain [44]. Obviously, further studies are needed to explore the 
role of BDNF in stress responses. Moreover, it is possible that variability of BDNF may be 
conditioned by small differences, for example, in the PCR method, experimental conditions or in the 
dynamics of neurochemical interrelated changes arising in the brain under psychoemotional 
stress.  
Transcription of BDNF is dependent on cAMP response element binding protein (CREB). We 
found a decreased Creb mRNA level in the raphe nuclei in 21-time losers in comparison with the 
controls. On the contrary, in other studies an increase in Creb gene expression was found in the 
hippocampus [45] of CRE-luciferase transgenic mice, and in the dorsal raphe of rats [46] after 21 days 
and 5 weeks of CSDS, respectively. The opposite role of CREB in depression and antidepressants’ 
effects depending on designs of experiments was repeatedly suspected [13]. Some authors suggested 
that CREB may play different roles depending on the brain region involved [47]. Different data on the 
changes in Creb mRNA levels and, as consequences, in Bdnf gene expression, could be explained by 
transient (dynamic) changes of gene expression as shown for many genes, including the genes of 
kappa-opioid receptors [9,48], mu-opioid receptors [49,50], and proenkephalin [51] in some brain 
areas in response to exposure to different experimental settings. This is consistent with the ideas 
mentioned earlier: the expression of some genes may increase rapidly and decrease abruptly, while the 
expression of other genes changes gradually [52]. In any case, the above data provides evidence of the 
involvement of the Bdnf and Creb genes, which encode the proteins associated with 
neurotransmission, neurogenesis and synaptic plasticity [53] in the consequences of CSDS. It is 
noteworthy that no significant changes in Creb mRNA levels were found in the losers after the period 
of relative rest.  
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.6
54
3.
1 
: P
os
te
d 
18
 O
ct
 2
01
1
 10
Research evidence shows that BDNF promotes the survival and differentiation of 5-HT neurons 
[54]. It is reasonable to assume that changes in the functional activity of the Creb and Bdnf genes in 
the raphe nuclei containing the cell bodies of serotonergic neurons may be conditioned by dynamic 
changes of serotonergic activity during the development of experimental depression. It has previously 
been shown [3] that at the initial stage (3 days of social stress) 5-НТ level increases in some brain 
areas. Decreased 5-hydroxyindoleacetic acid (5-HIAA) levels in the hippocampus, amygdala and 
nucleus accumbens as well as pharmacological desensitization and a decreased number of 5-НТ1А 
receptors were detected in the frontal cortex and amygdala at the stage of evolving depression (10 days 
of social stress). Interestingly, Maoa and Sert mRNA levels in the raphe nuclei were found to increase 
in the 10-days CBA/Lac defeaters [8]. At the stage of mixed anxiety/depression state (21 days of 
CSDS) an increased number of 5-НТ1А receptors and its decreased affinity in the amygdala [55] as 
well as reduced TPH and MAOA activities in the hippocampus [56] were found in the losers as 
compared with the controls. Hypofunction and, possibly, depletion of the brain serotonergic system 
was assumed to be a result of its prolonged activation under CSDS in animals [3,37]. Now we can say 
that this hypofunction may be due to down-regulation of the Tph2, Sert, MaoA and Htr1a genes 
involved in functioning serotonergic system.  
Interestingly, the total time of avoidance behavior which the losers demonstrate during agonistic 
interactions with aggressive winners is correlated with mRNA levels of the Gapdh, Bdnf, Sert, and 
Maoa genes. It is the avoidance behavior, rather than active and passive defense, which largely 
depends on the behavior of the aggressor, displays the anxiety and fear in the losers. The fact that there 
are positive correlations between mRNA levels of the Sert, and Maoa genes and level of anxiety is not 
surprising since SERT and MAOA are obviously involved in serotonergic mediation of the stress, 
anxiety and depression.  
It was shown many times that mixed anxiety/depression-like state developing in male mice after 
21 days CSDS experience accompanies by pronounced anxiety, behavioral deficit, anhedonia, 
decreased stress reactivity, indifference, social avoidance, depressiveness, psychosomatic changes etc, 
[1,3,6]. Many of these changes persist in the losers after 2 weeks of living in comfortable conditions - 
without social confrontations and defeats [17]. These data were confirmed by Berton et al. [33] who 
demonstrated avoidance behavior toward aggressor mice after three weeks of relative rest in the 
defeaters in similar experimental design. Noteworthy, reduced expression of the Tph2, Sert, Maoa, 
Htr1a genes in the raphe nuclei of depressive animals was not restored to the control level after a 2-
weeks of relative rest. It was hypothesized earlier [57] that the persistence of behavioral pathology 
may be due to sustained changes in the expression of genes encoding proteins involved in the 
development of depression under CSDS. Results of this experiment confirmed this assumption. 
It is well known that antidepressants improve the depression state in humans. Nevertheless in 
many cases these drugs do not prevent depression relapse or recurrence [58-60]. Our experimental 
approach may be useful for the seeking possible ways of pharmacological correction to prevent 
depressive relapse in patients. Modeling transitions from anxiety to depression [1,39] under CSDS 
may help in understanding the mechanisms and the role of different genes in the development of 
mixed anxiety/depression state. 
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